Supporting the LCA Community
We see a cure for blindness
Living with LCA
Since 2014, we’ve supported the LCA community with education, resources, and connections that strengthen and unite individuals and families across the IRD community.
Get Involved
Our donors and corporate partners drive our mission, helping us impact lives of those with LCA and rare IRDs. Learn about events, sponsorships, and partnerships.
Finding a Cure
By supporting the ecosystem that develops treatments for blinding diseases, we can advance therapies to approval. Join us in making these breakthroughs possible.
Learn Through Stories & Videos
What’s New
Episode 14 – The Latest in LCA1 and LCA4 Research with Dr. Paul Yang
In this episode, host Ben Shaberman, Science Communications Advisor to Hope in Focus, welcomes Dr. Paul Yang of the Casey Eye Institute at Oregon Health & Science University. A leading clinical researcher for inherited retinal diseases, Dr. Yang discusses promising results for clinical trials of LCA1 and LCA4 gene therapies, and how optogenetics shows potential […]
LCA13 (RDH12) Gene Therapy Poised to Move into Clinical Trial
Opus Genetics has received authorization from the US Food and Drug Administration (FDA) to launch a Phase 1/2 clinical trial for its emerging gene therapy for people with Leber congenital amaurosis 13 (LCA13) which is caused by mutations in the gene RDH12. The company plans to enroll 10 people in the trial including adolescents (ages […]
Dinner in the Dark
October 24, 2026 • Foxwoods Resort and Casino, Mashantucket, CT Our primary fundraiser for the year, this event is a true culinary adventure! You will enjoy a gourmet dinner while wearing a blindfold, and we keep the menu secret. Come learn about the exciting ways we are working to transform the lives of those without […]
Did You Know?
genetic mutations can cause LCA
raised to support research and community programs
countries in our global reach
Our Corporate Sponsors
